ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,632.33
1.05%
Dow Jones
41,488.19
1.65%
Gold vs US Dollar
2,986.65
0.00%
Brent Oil
70.285
0.00%
Bitcoin
83,897.95
-0.07%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Geron Corp (GERN)

  7. Geron Corp (GERN) News

Geron (GERN)

Geron Corp
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GERN
DateTimeSourceHeadlineSymbolCompany
11/03/202520:54Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GERNGeron Corp
03/03/202511:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GERNGeron Corp
03/03/202511:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GERNGeron Corp
03/03/202511:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GERNGeron Corp
26/02/202512:30Business WireGeron Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business HighlightsNASDAQ:GERNGeron Corp
21/02/202514:00Business WireGeron to Participate at Upcoming Investor Conferences in March 2025NASDAQ:GERNGeron Corp
19/02/202521:15Business WireGeron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GERNGeron Corp
03/02/202514:00Business WireGeron to Announce Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025NASDAQ:GERNGeron Corp
21/01/202521:30Business WireGeron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GERNGeron Corp
13/01/202513:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GERNGeron Corp
10/01/202521:05Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:GERNGeron Corp
02/01/202521:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GERNGeron Corp
19/12/202421:30Business WireGeron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GERNGeron Corp
13/12/202411:36Business WireGeron Announces Positive CHMP Opinion for RYTELO™ (imetelstat) for the Treatment of Adults with Transfusion-Dependent Anemia due to Lower-Risk MDSNASDAQ:GERNGeron Corp
10/12/202414:00Business WireGeron Announces New IMerge Analyses Presented at ASH Suggesting Clinical Activity of RYTELO™ (imetelstat) in Patients with Lower-Risk MDS Regardless of Type or Number of Prior TherapiesNASDAQ:GERNGeron Corp
10/12/202414:00Business WireGeron Announces Phase 1 Findings from Two-Part IMproveMF Study Presented at ASH Suggesting Tolerability of RYTELO™ (imetelstat) in Combination with Ruxolitinib as Frontline Therapy in Patients with MyelofibrosisNASDAQ:GERNGeron Corp
27/11/202414:00Business WireGeron to Participate in the 7th Annual Evercore ISI HealthCONx ConferenceNASDAQ:GERNGeron Corp
21/11/202421:30Business WireGeron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GERNGeron Corp
14/11/202414:31Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:GERNGeron Corp
14/11/202411:25Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:GERNGeron Corp
11/11/202421:30Business WireGeron Corporation Announces Appointment of Joseph Eid, M.D. as Executive Vice President, Research and DevelopmentNASDAQ:GERNGeron Corp
11/11/202414:00Business WireGeron to Participate in the Stifel 2024 Healthcare ConferenceNASDAQ:GERNGeron Corp
07/11/202412:10GlobeNewswire Inc.Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 MillionNASDAQ:GERNGeron Corp
07/11/202412:01Business WireGeron Corporation Announces Up to $375 Million in Funding with Royalty Pharma and Pharmakon AdvisorsNASDAQ:GERNGeron Corp
07/11/202412:00Business WireGeron Corporation Reports Third Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:GERNGeron Corp
05/11/202414:00Business WireGeron Announces New Data to be Presented at Upcoming ASH Annual Meeting Highlighting the Potential of RYTELO™ (imetelstat) in Myeloid Hematologic MalignanciesNASDAQ:GERNGeron Corp
17/10/202420:30Business WireGeron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GERNGeron Corp
15/10/202420:30Business WireGeron to Announce Third Quarter 2024 Financial Results on November 7, 2024NASDAQ:GERNGeron Corp
19/09/202420:30Business WireGeron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GERNGeron Corp
09/09/202420:35Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:GERNGeron Corp
 Showing the most relevant articles for your search:NASDAQ:GERN

Your Recent History

NYSE
DECK
Deckers Outdoor
AMEX
CRUZ
Defiance Hotel Airline a...
LSE
CSN
Chesnara
BIT
F14379
Vontobel Financial Produ...
BIT
T00006
Intesa Sanpaolo
NYSE
JMIA
Jumia Technologies
BIT
3LMI
Graniteshares 3x Long Mi...
NYSE
SLB
Schlumberger
DBI
IYX3
MSCI USA Minimum Volatil...
NYSE
JUN
Juniper II
AMEX
IXC
iShares Global Energy
LSE
THUS
Thus
NYSE
JWN
Nordstrom
LSE
DPD
DBI
LZM4
DAXglobal Asia Technolog...
AMEX
SME
ML Semicnd Mitt10/07
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2025 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads